Differential Diagnosis of Suspected Multiple Sclerosis in Pediatric and Late-Onset Populations: A Review.


Journal

JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536

Informations de publication

Date de publication:
16 Sep 2024
Historique:
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: aheadofprint

Résumé

While the typical onset of multiple sclerosis (MS) occurs in early adulthood, 2% to 10% of cases initially present prior to age 18 years, and approximately 5% after age 50 years. Guidance on approaches to differential diagnosis in suspected MS specific to these 2 age groups is needed. There are unique biological factors in children younger than 18 years and in adults older than age 50 years compared to typical adult-onset MS. These biological differences, particularly immunological and hormonal, may influence the clinical presentation of MS, resilience to neuronal injury, and differential diagnosis. While mimics of MS at the typical age at onset have been described, a comprehensive approach focused on the younger and older ends of the age spectrum has not been previously published. An international committee of MS experts in pediatric and adult MS was formed to provide consensus guidance on diagnostic approaches and key clinical and paraclinical red flags for non-MS diagnosis in children and older adults.

Identifiants

pubmed: 39283621
pii: 2823593
doi: 10.1001/jamaneurol.2024.3062
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Le H Hua (LH)

Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, Nevada.

Andrew J Solomon (AJ)

Larner College of Medicine at the University of Vermont, Burlington.

Silvia Tenembaum (S)

Department of Neurology, National Pediatric Hospital Dr J. P. Garrahan, Buenos Aires, Argentina.

Antonio Scalfari (A)

Centre for Neuroscience, Department of Medicine, Charing Cross Hospital, Imperial College London, London, United Kingdom.

Àlex Rovira (À)

Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Kevin Rostasy (K)

Children's Hospital Datteln, University Witten/Herdecke, Witten, Germany.

Scott D Newsome (SD)

Johns Hopkins University School of Medicine, Baltimore, Maryland.

Ruth Ann Marrie (RA)

Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Melinda Magyari (M)

Danish Multiple Sclerosis Center, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Orhun Kantarci (O)

Department of Neurology, Mayo Clinic, Rochester, Minnesota.

Bernhard Hemmer (B)

Department of Neurology, Technical University of Munich, Munich, Germany.
Munich Cluster for Systems Neurology, Munich, Germany.

Cheryl Hemingway (C)

Paediatric Neurology, Great Ormond Street Children's Hospital, London, United Kingdom.
Institute of Neurology, University College London, London, United Kingdom.

Mary Pat Harnegie (MP)

Cleveland Clinic Libraries, Cleveland Clinic, Cleveland, Ohio.

Jennifer S Graves (JS)

Department of Neurosciences, University of California, San Diego.

Jeffrey A Cohen (JA)

Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio.

Riley Bove (R)

UCSF Weill Institute for Neurosciences, University of California, San Francisco.

Brenda Banwell (B)

Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

John R Corboy (JR)

Department of Neurology, University of Colorado, School of Medicine, Aurora.

Emmanuelle Waubant (E)

UCSF Weill Institute for Neurosciences, University of California, San Francisco.

Classifications MeSH